Login / Signup

Prevention of severe immune-related colitis caused by combined immune checkpoint inhibition using vedolizumab: A Case report.

J JochmannA FinkA StellaR FeldmannL KramerC Posch
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • ulcerative colitis
  • early onset